Adverse events247

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 247

Type	Event	Organ system	Group	Affected	At risk	Events
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 Low Temperature : Placebo	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 Low Temperature : Proprannolol	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 Low Temperature : Dantrolene	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 Low Temperature : Magnesium	1	16	1
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 Low Temperature : Pindolol	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 High Temperature : Placebo	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 High Temperature : Proprannolol	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 High Temperature : Dantrolene	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 High Temperature : Magnesium	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 1 High Temperature : Pindolol	0	16
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Placebo	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Caffeine	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Naltrexone	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Qsymia	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Topiramate	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 2 : Phentermine	0	18
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 3 : Placebo	0	13
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 3 : Mirabegron 50mg	0	13
other	Asymptomatic non-sustained ventricular tachycardia	Cardiac disorders	Cohort 3 : Mirabegron 200mg	0	13
other	Catheter-related asymptomatic uncomplicated right upper extremity superficial venous thrombophlebiti	Blood and lymphatic system disorders	Cohort 1 Low Temperature : Placebo	0	16

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01950520/events

API reference For AI assistants

Adverse events247

Sources 3

Read this list from software.